<p>Mortality and cardiovascular outcomes in randomized controlled trials comparing angiotensin receptor antagonists and ACE inhibitors versus ACE inhibitors alone in patients with heart failure.</p
ObjectivesThe goal of the study was to assess the effects of angiotensin-converting enzyme inhibitor...
Aims: Although active-controlled trials with renin–angiotensin inhibitors are ethically mandated in ...
Forest plot of risk ratios (with 95% confidence intervals) of cardiovascular mortality for higher do...
<p>Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and AC...
Angiotensin receptor blockers (ARBs) are a valuable option to reduce cardiovascular (CV) mortality a...
Aims: The angiotensin-receptor-neprilysin inhibitor (ARNI) LCZ696 reduced cardiovascular deaths and ...
<p>ACE-I angiotensin-converting enzyme inhibitor, MI myocardial infarction, n number, NA not availab...
BACKGROUND: There is insufficient evidence whether the benefit of adding angiotensin II receptor blo...
<p>Abbreviations: ARB angiotensin II receptor antagonist, ACE angiotensin-converting enzyme, BP bloo...
International audienceAngiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blo...
BACKGROUND: Clinical trials in heart failure have focused on the improvement in symptoms or decrease...
Background—Clinical trials in heart failure have focused on the improvement in symptoms or decreases...
Background: Angiotensin converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARB...
<p>ACE-I angiotensin-converting enzyme inhibitor, EF ejection fraction, MI myocardial infarction, n ...
There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs)...
ObjectivesThe goal of the study was to assess the effects of angiotensin-converting enzyme inhibitor...
Aims: Although active-controlled trials with renin–angiotensin inhibitors are ethically mandated in ...
Forest plot of risk ratios (with 95% confidence intervals) of cardiovascular mortality for higher do...
<p>Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and AC...
Angiotensin receptor blockers (ARBs) are a valuable option to reduce cardiovascular (CV) mortality a...
Aims: The angiotensin-receptor-neprilysin inhibitor (ARNI) LCZ696 reduced cardiovascular deaths and ...
<p>ACE-I angiotensin-converting enzyme inhibitor, MI myocardial infarction, n number, NA not availab...
BACKGROUND: There is insufficient evidence whether the benefit of adding angiotensin II receptor blo...
<p>Abbreviations: ARB angiotensin II receptor antagonist, ACE angiotensin-converting enzyme, BP bloo...
International audienceAngiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blo...
BACKGROUND: Clinical trials in heart failure have focused on the improvement in symptoms or decrease...
Background—Clinical trials in heart failure have focused on the improvement in symptoms or decreases...
Background: Angiotensin converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARB...
<p>ACE-I angiotensin-converting enzyme inhibitor, EF ejection fraction, MI myocardial infarction, n ...
There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs)...
ObjectivesThe goal of the study was to assess the effects of angiotensin-converting enzyme inhibitor...
Aims: Although active-controlled trials with renin–angiotensin inhibitors are ethically mandated in ...
Forest plot of risk ratios (with 95% confidence intervals) of cardiovascular mortality for higher do...